A newly released educational resource provides a detailed, research-informed examination of “ TMS and ...

Florida ranks third in the nation for the number of high-performing home health agencies. The ratings are based on data from ...

Huntington Beach, California - February 24, 2026 - PRESSADVANTAGE - A newly released educational resource provides a ...

People with ADHD face greater physical health risks and higher rates of premature mortality. But there are ways to address these inequities.

Chronic cough has not traditionally been listed as a common adverse effect of GLP-1s. According to Jeff Stanley, MD, ...

Labor has been warned of critical failures in Australia’s medical safety programs, which are leaving vulnerable Australians at risk of preventable hospitalisations.

Nearly seven in 10 Americans who have taken a GLP-1 medication say the drug’s cost influenced their decision to start or ...

The Tennessee Poison Center is seeing a sharp increase in calls related to tirzepatide and semaglutide exposure over the last five years.

Village Caregiving reports that 75% of seniors prefer aging in place. The guide offers safety tips and solutions for enhancing senior home safety.

Cost concerns among GLP-1 users extend beyond individual financial strain to perceptions of broader health care system sustainability. More than 70% of respondents supported minimum coverage ...

The FDA has approved a new four-dose, single-patient-use KwikPen for Zepbound (tirzepatide), giving patients a full month of treatment in one device.

The FDA has approved a label expansion for once-weekly tirzepatide for adults with overweight and obesity, allowing the medication to be used with a pen that is equipped with four doses of the drug, ...